Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2000
06/07/2000CN1255636A Method and equipment for monitoring running state of pollution treating apparatus set
06/07/2000CN1255552A Universal microarray
06/07/2000CN1255379A Identification method of compound for inhibiting tumour injury and medicinal compsns. containing said compound
06/07/2000CN1255376A Method of enhancing crude drugs anti-tumour activity
06/07/2000CN1053276C Method for detecting antibody of islet-cells
06/06/2000US6073047 Method and apparatus for diagnosis, detection of cell abnormalities and morphology of living systems
06/06/2000US6072319 Device for measuring properties of a textile product
06/06/2000US6072314 NMR interpretation technique using error minimization with variable T2 cutoff
06/06/2000US6072309 Paper stock zeta potential measurement and control
06/06/2000US6072041 Single chain fv molecule directed against a transcytotic receptor covalently linked to a therapeutic protein; to deliver therapy to the other side of a cell
06/06/2000US6072039 Hybrid polypeptide comparing a biotinylated avidin binding polypeptide fused to a polypeptide of interest
06/06/2000US6072037 Antibodies to the IL-17 receptor
06/06/2000US6072033 Receptor that binds IL-17
06/06/2000US6072032 Amino acid sequence of polypeptide involved in protein secretory apparatus of bacteria; for screening for bactericides and bacteriostats; diagnosis of and prophylaxis for infections
06/06/2000US6072028 Amino acid sequence of effector cell protease receptor-1, a transmembrane glycoprotein receptor for factor xa; immunosuppressants for autoimmune disorders; suppression or activation of lymphocyte proliferation; diagnosis of disease
06/06/2000US6072022 Useful for facilitating the separation of blood serum or plasma from the cellular portion of blood.
06/06/2000US6071969 Substituted aminoguanidines and methods of use thereof
06/06/2000US6071894 Sensor histidine kinase of Staphylococcus aureus
06/06/2000US6071892 Polynucleotides that encode the polypeptide of tyrosyl synthetase have amino acid homology to a known bacillus subtilis tyrosyl trna synthetase protein
06/06/2000US6071889 In vivo genetic modification of growth factor-responsive neural precursor cells
06/06/2000US6071747 Human preadipocytes for developing antiobesity and antidiabetic agents; cells include immortalizing fragment of viral oncogene, promoter from viral oncogene or human vimentin gene, and express certain proteins
06/06/2000US6071739 Sample analyzer
06/06/2000US6071737 Equine Neospora isolate and its uses
06/06/2000US6071736 Process and culture medium for the production of cells infected by a multiple sclerosis-associated virus
06/06/2000US6071734 Ribonuclease h from human hepatitis b virus; for recombinant production and identifying enzyme inhibitors
06/06/2000US6071732 Tyrosylprotein sulfotransferases, nucleic acids encoding tyrosylprotein sulfotransferases, and methods of use thereof
06/06/2000US6071731 Enzymatic polypeptide for the attachment of histidine to transfer ribonucleic acid molecule; bactericides; wound healing agents
06/06/2000US6071724 Streptococcus pneumoniaegene sequence era
06/06/2000US6071722 Nucleic acids encoding a G-protein coupled 7TM receptor (AXOR-1)
06/06/2000US6071721 Calcium binding protein
06/06/2000US6071719 Polynucleotide sequence coding a membrane protein; for the treatment and prevention of infections
06/06/2000US6071717 Polycystic kidney disease gene and protein
06/06/2000US6071710 Antikinin compounds and uses thereof
06/06/2000US6071709 Nerve growth factor/receptor complex
06/06/2000US6071708 Morphogenic protein compositions of matter
06/06/2000US6071707 Phosphotyrosine mimics and method for identifying and using same
06/06/2000US6071706 Stabilising medium for alphagst in urine for use in an enzyme immunoassay
06/06/2000US6071705 Method of detecting neurological disease or dysfunction
06/06/2000US6071696 Method of producing a temporally spaced subtracted (TSS) CDNA library and use thereof to monitor differentiation
06/06/2000US6071691 Screening for modulators of cell differentiation; monitoring expression levels of a marker protein in suppressed cells, monitoring expression of marker protein after incubation with modulator
06/06/2000US6071522 Cloning of mite allergens
06/06/2000US6071520 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
06/06/2000US6071493 Method of screening for an agent that inhibits mononuclear phagocyte-plaque component complex formation
06/06/2000US6071491 Administering an antibody against cell ghosts, wherein the antibody is specific to an intracellular antigen not present on the cell surface of normal or neoplastic cells, and wherein the antibody is labeled
06/06/2000US6071395 Process and device for isolating nucleic acids
06/06/2000US6071394 Channel-less separation of bioparticles on a bioelectronic chip by dielectrophoresis
06/06/2000US6071393 Nitrogen oxide concentration sensor
06/06/2000US6071391 Enzyme electrode structure
06/06/2000US6071251 Method and apparatus for obtaining blood for diagnostic tests
06/06/2000US6071249 Method and apparatus for obtaining blood for diagnostic tests
06/06/2000US6070465 Free water measurement apparatus and method thereof
06/06/2000US6070456 Apparatus for evaluating fuel lubricity at elevated pressure conditions
06/06/2000US6070450 Multilayered gas sensor
06/06/2000CA2203627C Rapid detection and identification of nucleic acid variants and pathogens
06/06/2000CA2176672C Improved sample card
06/06/2000CA2060182C Resuspendable coated magnetic particles and stable magnetic particle suspensions
06/06/2000CA1341020C Lipoprotein i (ompi) of pseudomonas aeruginosa
06/06/2000CA1341015C Outer membrane protein f of pseudomonas aeruginosa
06/06/2000CA1341014C Hcg peptides for use in antibody purification procedures
06/06/2000CA1341013C Compositions and methods for clones containing dna sequences associated with multidrug resistance in human cells
06/02/2000WO2000031750A1 Electrically conductive electroactive functionalized conjugated polymers, and uses thereof
06/02/2000WO2000031548A1 Prevention and treatment of amyloid-associated disorders
06/02/2000WO2000031547A1 Prion protein standard and method of making same
06/02/2000WO2000031546A1 Antibodies to peptides that target git receptors and related methods
06/02/2000WO2000031545A1 Diagnosis of demyelinating or spongiform disease
06/02/2000WO2000031544A1 Method for modifying and identifying functional sites in proteins
06/02/2000WO2000031543A1 Measurement of hydride using chemiluminescent acridinium compounds
06/02/2000WO2000031542A1 Detection of t cell stimulating tumor antigens
06/02/2000WO2000031541A2 Method of detecting neurofibromatosis type 1
06/02/2000WO2000031539A1 Method and apparatus for performing a lateral flow assay
06/02/2000WO2000031538A1 Improved lateral flow assays
06/02/2000WO2000031537A1 Detection of biomolecules using phage reagents
06/02/2000WO2000031536A2 Detecting structural or synthetic information about chemical compounds
06/02/2000WO2000031535A2 Thyroid peroxidase autoantibody assay compositions, method and kit
06/02/2000WO2000031534A1 In situ method of analyzing cells
06/02/2000WO2000031533A1 Test kit and method of diagnosing severe acute pancreatitis
06/02/2000WO2000031532A1 Methods of identifying viral therapeutics
06/02/2000WO2000031531A1 Monitoring patient compliance and bioavailability of drugs by deproteinizing body fluids
06/02/2000WO2000031530A2 Screening of nos2 moldulators using p53 miutant cells
06/02/2000WO2000031529A1 Devices and methods for performing blood coagulation assays by piezoelectric sensing
06/02/2000WO2000031524A2 Electrode system
06/02/2000WO2000031517A1 Method and device for automated chromophore-assisted laser/light inactivation (cali)
06/02/2000WO2000031511A1 Abrasion tester
06/02/2000WO2000031306A2 Multiplex amplification of short tandem repeat loci
06/02/2000WO2000031305A2 Primer extension methods utilizing donor and acceptor molecules for detecting nucleic acids
06/02/2000WO2000031304A1 Methods and apparatus for flow-through hybridization
06/02/2000WO2000031303A2 Methods for stool sample preparation
06/02/2000WO2000031294A2 Method for identifying cytosine methylation patterns in genomic dna
06/02/2000WO2000031291A1 Method for screening for substances which are activators, inhibitors or binders of pkb by the use of a substrate peptide and the use of the substrate peptide
06/02/2000WO2000031290A1 Methods and compositions for pain management
06/02/2000WO2000031289A1 Use of activated trap for screening for specific inhibitor of trap and method for aiding in the identification of a compound for use in the treatment of diseases or degenerative conditions resulting in increased bone resorption
06/02/2000WO2000031288A1 Method for screening cd14 agonist or antagonist
06/02/2000WO2000031278A1 Zace1: a human metalloenzyme
06/02/2000WO2000031273A2 Process for oxidising terpenes
06/02/2000WO2000031265A1 Urotensins ii of mammals and their uses
06/02/2000WO2000031263A2 Gtpase associated proteins
06/02/2000WO2000031258A2 Human orphan g protein-coupled receptors
06/02/2000WO2000031253A2 Mutation of the parkin gene, compositions, methods and uses
06/02/2000WO2000031252A1 Human semaphorin 6a-1 (sema6a-a), a gene involved in neuronal development and regeneration mechanisms during apoptosis, and its use as a potential drug target
06/02/2000WO2000031248A1 Humanized monoclonal antibodies
1 ... 3109 3110 3111 3112 3113 3114 3115 3116 3117 3118 3119 3120 3121 3122 3123 3124 3125 3126 3127 3128 3129 ... 3937